Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Article number	22br03337
Journal	Primary Care Companion to the Journal of Clinical Psychiatry
Volume	24
Issue number	5
DOIs	https://doi.org/10.4088/PCC.22br03337
State	Published - 2022

All Science Journal Classification (ASJC) codes

@article{ecdf5530087045d7bb0647495db2a147,

title = "Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control Study",

author = "Diaz, \{Ailyn D.\} and Raman Baweja",

year = "2022",

doi = "10.4088/PCC.22br03337",

language = "English (US)",

volume = "24",

journal = "Primary Care Companion to the Journal of Clinical Psychiatry",

issn = "2155-7772",

publisher = "Physicians Postgraduate Press Inc.",

number = "5",

}

TY - JOUR

T1 - Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder

T2 - A Real-World Case-Control Study

AU - Diaz, Ailyn D.

AU - Baweja, Raman

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85139571747

UR - https://www.scopus.com/pages/publications/85139571747#tab=citedBy

U2 - 10.4088/PCC.22br03337

DO - 10.4088/PCC.22br03337

M3 - Comment/debate

C2 - 36206376

AN - SCOPUS:85139571747

SN - 2155-7772

VL - 24

JO - Primary Care Companion to the Journal of Clinical Psychiatry

JF - Primary Care Companion to the Journal of Clinical Psychiatry

IS - 5

M1 - 22br03337

ER -